Intervascular Imaging & Treatment Seminar
About
Dr. Giulio Guagliumi was trained with Master in Interventional Cardiology at the Clinique Pasteur, Toulouse, France. He was awarded at Mayo Clinic and St. Mary Hospital, Rochester in imaging and coronary physiology assessment of vascular response to intracoronary stents. He has a long-standing interventional practice with research expertise in acute myocardial infarction, stent, vascular biology, intravascular imaging, structural heart disease. Fellow of the Italian Society of Invasive Cardiology since 2003, he was the Scientific Director of the GISE Congress in 2008-2009 and President of the Italian Society in 2009-2011. H’s fellow of the ESC, member of EAPCI since 2004, member of the scientific committee and executive board of EUROPCR; Co-chair EAPCI Program Scientific Committee for the ESC Congress 2012-2014: Expert Chair of the same Committee in 2015. Country champion of the European Stent for Life project in 2010-2014, to correct inequalities in access to primary-PCI at Italian regional level. Promoter at the EAPCI level of the joint initiative with the largest Japanese society (CVIT). Professor emeritus 2013-2014 at the First Affiliated Hospital of Harbin Medical University. Since 2015, Dr. Guagliumi was training the interventional cardiology unit personnel at the Second Affiliated Hospital of the Harbin Medical University in clinical use of the intracoronary imaging, with focus on complex coronary artery disease. He worked as co-director with Prof. Yu and Prof. Jia in multiple national and international educational meetings held in Harbin, including the most recent ASIA Pacific Hybrid Course on actionable imaging. He was appointed as Honorary Professor at the Harbin Medical University in 2019.
During the COVID-19 disease period Dr. Guagliumi directed the Interventional Unit of PG23 Hospital, working for all cardiovascular emergencies of the entire Bergamo Province. H’s the leading author of the COVID-19 pathology research publications that identified microthrombi as the major cause of myocardial damage.
He has ongoing scientific collaboration with major Universities and research centers including Beckmann Laser Unit, University of California (Irvine), Case Western University (Cleveland, Ohio), Emory University (Atlanta), MIT (Boston), CV Path Institute (Gaithersburg), Wakayama University (Japan), Harbin Medical University (China). Principal investigator and member of the Steering Committee in multiple prospective, randomized, international multicenter trials in primary-PCI, coronary stenting, DES, intracoronary imaging (IVUS, OCT). Author of 273 peer reviewed scientific manuscripts, published across all prestigious cardiology journals, including New England Journal, Eur Heart Journal, Lancet, Circulation, JACC, JACC Imaging, Eurointervention. He has more than 300 peer reviewed Abstracts presented at the main international scientific conferences. Reviewer of: Eur Heart Journal, Circulation, Circ Interv, JACC, JACC Interv, JACC Imaging, Nature Cardiovascular Medicine, Eurointervention. Official grader of abstracts and clinical cases submitted to the main Congresses (EuroPCR, ESC, TCT, TCT AP, ENCORE etc). Dr. Guagliumi is the leading author of imaging chapters in multiple textbooks, including the OCT chapter of the Interventional Cardiology Textbook- (Editor Topol-Teirstein) for the 6, 7th, 8th edition and now officially charged lead author for the new update #9 version. In 2014 he was listed by Thomson Reuters among the most influential researcher in the last ten years from inCites and the Web of Science.
Biography
Dr. Guagliumi research interest combines scientific and medical training, expertise in conducting prospective, randomized trials, and leadership in the field of high-resolution imaging applied to evaluation of in-vivo stent vascular responses. Dr. Guagliumi a pioneer in clinical use of light-based imaging for evaluating coronary stenting in various prospective, randomized, controlled studies conducted in unstable coronary syndromes, including ST elevation myocardial infarction, and complex lesion settings (long lesions, diabetes, overlapping stents). His group has one of the largest existing experience in the world with Optical Coherence Tomography (OCT) to detect stent-tissue responses at different time points following implantation. His work is based on continuous confront and interaction with pathologists for validating OCT imaging signals and interpretation and develop surrogate imaging variables predicting stent failure. With this as a foundation the Guagliumi laboratory set the way for conducting innovative in-vivo evaluation and optimization of most of the clinically approved bare metal and drug-eluting stents. H’s involved in early evaluation/discussion of light based technical and software innovations for the clinical use, including OCT co-registration with coronary angiography, novel artificial intelligence software implementation for automatic EEL detection and calcium quantification. His most recent publications have focused on how light-based intracoronary imaging helps to identify heterogeneous mechanisms of stent thrombosis and define surrogate imaging variables for anticipating the individual risk profile. Dr. Guagliumi is involved in innovative invasive and non invasive imaging and physiology research projects, including the use of the light for plaque molding, and innovative blood flow measurements with CTCA.
